Author:
Ma Ting Martin,Neylon Jack,Casado Maria,Sharma Sahil,Sheng Ke,Low Daniel,Yang Yingli,Steinberg Michael L.,Lamb James,Cao Minsong,Kishan Amar U.
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference37 articles.
1. Network NCC. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. Version I.2019 ed2019.
2. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial;Widmark;Lancet (London, England),2019
3. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial;Brand;Lancet Oncol,2019
4. Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer;Kishan;JAMA Network Open,2019
5. Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies;Jackson;Int J Radiat Oncol Biol Phys,2019
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献